Detalles de la búsqueda
1.
Assessment of squalene adjuvanted and non-adjuvanted vaccines against pandemic H1N1 influenza in children 6 months to 17 years of age.
Hum Vaccin Immunother
; 8(9): 1283-92, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22906943
2.
Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 4, 6 and 12-14 months of age.
Vaccine
; 29(6): 1324-31, 2011 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21134456
3.
AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice.
Vaccine
; 28(18): 3076-9, 2010 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-20193791
4.
Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
Vaccine
; 27(19): 2540-7, 2009 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-19124057
5.
Improving seasonal and pandemic influenza vaccines.
Influenza Other Respir Viruses
; 2(6): 229-35, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19453399
6.
Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age.
Hum Vaccin
; 1(3): 112-7, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-17012870
7.
Safety and immunogenicity of two formulations of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae conjugate-hepatitis B vaccine in 15 to 18-month-old children.
Hum Vaccin
; 1(6): 245-50, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-17012871
8.
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety.
Vaccine
; 22(11-12): 1343-57, 2004 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-15063556
9.
Bacillary growth, interleukin 2 production defect, and specific antibody secretion governed by different genetical factors in mice infected subcutaneously with Mycobacterium lepraemurium
s.l; s.n; 1986. 14 p. tab, graf.
No convencional
en Inglés
| SES-SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, SES-SP | ID: biblio-1231450
10.
Strain variation of lymphokine production and specific antibody secretion in mice infected with Mycobacterium lepraemurium
s.l; s.n; 1985. 10 p. tab, graf.
No convencional
en Inglés
| SES-SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, SES-SP | ID: biblio-1233741
Resultados
1 -
10
de 10
1
Próxima >
>>